Related references
Note: Only part of the references are listed.Structural feature of TRAFs, their related human diseases and therapeutic intervention
Hyun Ho Park
ARCHIVES OF PHARMACAL RESEARCH (2021)
JAC1 suppresses proliferation of breast cancer through the JWA/p38/SMURF1/HER2 signaling
Yanlin Ren et al.
CELL DEATH DISCOVERY (2021)
Patient-Derived Xenograft Engraftment and Breast Cancer Outcomes in a Prospective Neoadjuvant Study (BEAUTY)
Judy C. Boughey et al.
CLINICAL CANCER RESEARCH (2021)
Antitumour immunity regulated by aberrant ERBB family signalling
Shogo Kumagai et al.
NATURE REVIEWS CANCER (2021)
HER2-targeted therapies - a role beyond breast cancer
Do-Youn Oh et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
The functions and regulation of Smurfs in cancers
Lin Fu et al.
SEMINARS IN CANCER BIOLOGY (2020)
High expression of TRAF4 predicts poor prognosis in tamoxifen-treated breast cancer and promotes tamoxifen resistance
Jun Zhou et al.
ANTI-CANCER DRUGS (2020)
TRAF4, a new substrate of SIAH1, participates in chemotherapy resistance of breast cancer cell by counteracting SIAH1-mediated downregulation of β-catenin
Huayan Ren et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Ubiquitin ligase SMURF2 enhances epidermal growth factor receptor stability and tyrosine-kinase inhibitor resistance
Paramita Ray et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Ubiquitin-proteasome system (UPS) as a target for anticancer treatment
Jinyoung Park et al.
ARCHIVES OF PHARMACAL RESEARCH (2020)
E3 ubiquitin ligase Smurf2: a prognostic factor in microsatellite stable colorectal cancer
Fee Klupp et al.
CANCER MANAGEMENT AND RESEARCH (2019)
TRAF4 positively regulates the osteogenic differentiation of mesenchymal stem cells by acting as an E3 ubiquitin ligase to degrade Smurf2
Jinteng Li et al.
CELL DEATH AND DIFFERENTIATION (2019)
Altered Expression and Localization of Tumor Suppressive E3 Ubiquitin Ligase SMURF2 in Human Prostate and Breast Cancer
Andrea Emanuelli et al.
CANCERS (2019)
TRAF Regulation of IL-17 Cytokine Signaling
Shadi Swaidani et al.
FRONTIERS IN IMMUNOLOGY (2019)
Herceptin: A First Assault on Oncogenes that Launched a Revolution
Charles L. Sawyers
CELL (2019)
Recognition of TRAIP with TRAFs: Current understanding and associated diseases
Nasreena Sajjad et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2019)
Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2019)
Linear ubiquitin chain-binding domains
Lilian M. Fennell et al.
FEBS JOURNAL (2018)
TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis
Ramesh Singh et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Mechanisms Underlying the Action and Synergism of Trastuzumab and Pertuzumab in Targeting HER2-Positive Breast Cancer
Babak Nami et al.
CANCERS (2018)
Smurfs in Protein Homeostasis, Signaling, and Cancer
Praveen Koganti et al.
FRONTIERS IN ONCOLOGY (2018)
TRAF4 binds to the juxtamembrane region of EGFR directly and promotes kinase activation
Gang Cai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
An integrated bioinformatics platform for investigating the human E3 ubiquitin ligase-substrate interaction network
Yang Li et al.
NATURE COMMUNICATIONS (2017)
The ubiquitin ligase Smurf2 suppresses TGFβ-induced epithelial-mesenchymal transition in a sumoylation-regulated manner
A. S. Chandhoke et al.
CELL DEATH AND DIFFERENTIATION (2016)
TRAF4-SMURF2-Mediated DAZAP2 Degradation Is Critical for IL-25 Signaling and Allergic Airway Inflammation
Jarod A. Zepp et al.
JOURNAL OF IMMUNOLOGY (2015)
Targeting PI3K/mTOR Overcomes Resistance to HER2-Targeted Therapy Independent of Feedback Activation of AKT
Neil A. O'Brien et al.
CLINICAL CANCER RESEARCH (2014)
Herceptin Resistance Database for Understanding Mechanism of Resistance in Breast Cancer Patients
Sahil Ahmad et al.
SCIENTIFIC REPORTS (2014)
Targeting focal adhesion kinase in ER+/HER2+breast cancer improves trastuzumab response
Glorianne Lazaro et al.
ENDOCRINE-RELATED CANCER (2013)
Ubiquitination of Tumor Necrosis Factor Receptor-associated Factor 4 (TRAF4) by Smad Ubiquitination Regulatory Factor 1 (Smurf1) Regulates Motility of Breast Epithelial and Cancer Cells
Xiangchun Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Coordination of TGF-β Signaling by Ubiquitylation
Aristidis Moustakas et al.
MOLECULAR CELL (2013)
TRAF4 Promotes TGF-β Receptor Signaling and Drives Breast Cancer Metastasis
Long Zhang et al.
MOLECULAR CELL (2013)
Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies
Ariella B. Hanker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Frequent Mutational Activation of the PI3K-AKT Pathway in Trastuzumab-Resistant Breast Cancer
Sarat Chandarlapaty et al.
CLINICAL CANCER RESEARCH (2012)
Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients
Maurizio Scaltriti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Regulation of EGFR Protein Stability by the HECT-type Ubiquitin Ligase SMURF2
Dipankar Ray et al.
NEOPLASIA (2011)
TRAF4, at the Crossroad between Morphogenesis and Cancer
Adrien Rousseau et al.
Cancers (2011)
Primary trastuzumab resistance: new tricks for an old drug
Jason A. Wilken et al.
TOWARD PERSONALIZED MEDICINE FOR CANCER (2010)
Ubiquitin ligase Smurf1 targets TRAF family proteins for ubiquitination and degradation
Shan Li et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
HER2 Phosphorylation Is Maintained by a PKB Negative Feedback Loop in Response to Anti-HER2 Herceptin in Breast Cancer
Merel Gijsen et al.
PLOS BIOLOGY (2010)
Resistance to Trastuzumab in Breast Cancer
Paula R. Pohlmann et al.
CLINICAL CANCER RESEARCH (2009)
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer
Katrien Berns et al.
CANCER CELL (2007)
The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis
M. M. Moasser
ONCOGENE (2007)
A quantitative protein interaction network for the ErbB receptors using protein microarrays
RB Jones et al.
NATURE (2006)
MEKK4 is an effector of the embryonic TRAF4 for JNK activation
AN Abell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Parsing ERK activation reveals quantitatively equivalent contributions from epidermal growth factor receptor and HER2 in human mammary epithelial cells
BS Hendriks et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Involvement of TRAF4 in oxidative activation of c-Jun N-terminal kinase
YX Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Tumor necrosis factor receptor-associated factors (TRAFs)
JR Bradley et al.
ONCOGENE (2001)
HER2/Neu: mechanisms of dimerization/oligomerization
PJ Brennan et al.
ONCOGENE (2000)
Share Paper
